16.49
0.55%
+0.09
Catalyst Pharmaceuticals Inc Aktie (CPRX) Neueste Nachrichten
Jump Financial LLC Has $1.08 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Defense World
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Amalgamated Bank Reduces Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Defense World
Catalyst Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
MarketWatch
Victory Capital Management Inc. Reduces Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
MarketBeat
Victory Capital Management Inc. Decreases Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Defense World
Catalyst Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch
MarketWatch
Boston Partners Grows Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
MarketBeat
Implied Volatility Surging for Catalyst Pharmaceuticals (CPRX) Stock Options - Yahoo Canada Shine On
Yahoo Canada Shine On
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
The Motley Fool
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings Estimates - Yahoo Movies UK
Yahoo Movies UK
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Catalyst Pharmaceuticals (NASDAQ:CPRX) PT Raised to $26.00 - Defense World
Defense World
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by New York State Common Retirement Fund - Defense World
Defense World
StockNews.com Lowers Catalyst Pharmaceuticals (NASDAQ:CPRX) to Hold - Defense World
Defense World
Catalyst Pharmaceuticals (NASDAQ:CPRX) Downgraded to "Hold" at StockNews.com - MarketBeat
MarketBeat
Catalyst Pharmaceuticals (CPRX) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Relay Therapeutics, Inc. (RLAY) Surges 13.8%: Is This an Indication of Further Gains? - Yahoo Movies Canada
Yahoo Movies Canada
Los Angeles Capital Management LLC Sells 41330 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Defense World
HC Wainwright Increases Catalyst Pharmaceuticals (NASDAQ:CPRX) Price Target to $26.00 - MarketBeat
MarketBeat
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Decoding 8 Analyst Evaluations For Catalyst Pharmaceuticals - Catalyst Pharmaceuticals (NASDAQ:CPRX) - Benzinga
Benzinga
Catalyst Pharmaceuticals First Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St
Simply Wall St
(CPRX) Investment Analysis and Advice - Stock Traders Daily
Stock Traders Daily
Earnings call: Catalyst Pharmaceuticals Q1 2024 shows robust growth - Investing.com South Africa
Investing.com South Africa
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Earnings call: Catalyst Pharmaceuticals Q1 2024 shows robust growth - Investing.com Canada
Investing.com Canada
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues - Yahoo Finance
Yahoo Finance
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues - Zacks Investment Research
Zacks Investment Research
Cantor Fitzgerald Maintains Catalyst Pharmaceuticals (CPRX) Overweight Recommendation - MSN
MSN
Catalyst Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
MarketWatch
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - 08.05.2024 - wallstreet:online
wallstreet:online
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com
br.ADVFN.com
Catalyst (CPRX) Up More Than 20% in Past 3 Months: Here's Why - Yahoo Movies UK
Yahoo Movies UK
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance
Yahoo Finance
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
Zacks Investment Research
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
Zacks Investment Research
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
MarketWatch
Yousif Capital Management LLC Sells 3164 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Defense World
Catalyst Pharmaceutical (CPRX) Gains But Lags Market: What You Should Know - Yahoo Movies UK
Yahoo Movies UK
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks Investment Research
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Kapitalisierung:
|
Volumen (24h):